Table 1 Characteristics of the included studies.

From: Cognitive behavioral therapy for anxiety and depression in cancer survivors: a meta-analysis

Study (area)

Type of cancer

Stage

n, M/F

Treatment time

Follow-up

Groups

Case

Age, years

M/F

Outcomes

Intervention

Quantitative analysis

Fenlon, D 2020 (UK)

Breast

NR

127, 0/127

6 weeks

6 months

CBT

61

53.5 ± 9.78

0/61

PHQ, GAD-7

Weekly group CBT sessions, lasting 90 min, for 6 weeks

TAU

66

55.2 ± 10.19

0/66

Groarke, A 2013 (Ireland)

Breast

Any

179, 0/179

5 weeks

12 months

CBT

87

53.30 ± 9.86

0/87

HADS-D, HADS-A

In groups of 8–12 for 3 h per week

TAU

92

54.10 ± 10.62

0/92

Ham, K 2019 (South Korea)

Mixed

I-IV

42, 6/36

10 weeks

NR

CBT

21

41.90 ± 11.30

3/18

DAS, STAI

One session per day for a total of 10 weeks at home

TAU

21

47.10 ± 11.19

3/18

Jelvehzadeh, F 2022 (Iran)

Breast

Any

48, 0/48

8 weeks

3 months

CBT

24

49.40 ± 7.22

0/24

DASS-21

Three groups of 8 were formed and 8 sessions were held for each group

TAU

24

47.94 ± 6.99

0/24

Murphy, MJ 2020 (Australia)

Mixed

early

114, 13/101

16 weeks

3 months

CBT

53

53.28 ± 9.22

7/46

HADS-D, HADS-A

Online self-managed but clinician supervised, 16-week, 8-lesson program

TAU

61

53.30 ± 10.09

6/55

Qiu, J 2013 (China)

Breast

0-IV

62, 0/62

10 weeks

6 months

CBT

31

51.68 ± 5.95

0/31

HAMD, SAS

Treatment protocol-guided group, weekly for 10 two-hour sessions

TAU

31

49.58 ± 8.03

0/31

Savard, J 2005 (Canada)

Breast

I-III

58, 0/58

8 weeks

12 months

CBT

27

54.81 ± 7.01

0/27

HADS-D, HADS-A

Eight weekly sessions of 90 min, offered in groups of four to six patients

TAU

30

53.37 ± 7.72

0/30

Savard, J 2006 (Canada)

Breast

metastatic

45, 0/37

8 weeks

6 months

CBT

21

51.47 ± 8.05

0/21

HADS-D, HADS-A

Eight weekly sessions of 60 to 90 min, individually

TAU

16

51.66 ± 8.62

0/16

Serfaty, M 2019 (UK)

Mixed

Any

230, 78/152

12 weeks

3 months

CBT

115

59.5 ± 10.3

41/74

BDI-2

Twelve weekly sessions of individual CBT delivered

TAU

115

59.5 ± 12.4

37/78

Sheikhzadeh, M 2021 (Iran)

Mixed

Any

39, 7/32

8 weeks

NR

CBT

19

40.10 (mean)

1/18

BDI, BAI

Eight weekly 90-min sessions were held in a room of hospital

TAU

20

37.45 (mean)

6/14

Trask, PC 2003 (USA)

Melanoma

0-III

48, 14/34

4 weeks

6 months

CBT

25

56.2 (30–92)

8/17

STAI

Three 50-min weekly group sessions for 4 weeks

TAU

23

51.0 (22–71)

6/17

van de Wal, M 2017 (Netherland)

Mixed

NR

88, 41/47

8 weeks

NR

CBT

45

58.0 ± 11.3

21/24

HADS-D, HADS-A

Five individual 1 h session, with three 15-min e-consultations

TAU

43

59.7 ± 10.0

20/23

Yang, Y 2022 (China)

LSCC

NR

80, 66/14

2 weeks

NR

CBT

40

51.05 ± 3.66

34/6

SAI, PHQ-9

Five sessions, and each session took about 20 min, individually

TAU

40

51.13 ± 3.52

32/8

Qualitative analysis

Duffy, SA 2006 (USA)

HNC

Any

184, 155/29

NR

6 months

CBT

93

56 ± 10.8

72/21

GDSSF

9–11 sessions of CBT telephone counseling

TAU

91

58 ± 8.9

83/8

Savard, J 2014 (Canada)

Breast

0–III

242, 0/242

6 weeks

6 months

CBT

81

52.6 ± 8.9

0/81

HADS-D, HADS-A

Six weekly, individual treatment sessions of approximately 50 min

TAU

81

55.4 ± 8.8

0/81

  1. F, female; M, male; NR, not reported; HNC, Head and Neck Cancer; LSCC, laryngeal squamous cell carcinoma; GDSSF, Geriatric Depression Scale-Short Form; GAD-7, general anxiety disorder; PHQ, patient health questionnaire; STAI, State-Trait Anxiety Inventory scores; DASS-21, The Depression Anxiety Stress Scales 21; HAMD, 17-Item Hamilton Depression Rating Scale; HAMA, Hamilton anxiety scale; SAS, Self-Rating Anxiety Scale; BDI-2, Beck Depression Inventory, version 2; BAI, Beck Anxiety Inventory; SAI, Spielberger State Anxiety Inventory; DAS, Dysfunctional Attitudes Scale.